Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

AccesswireDec 5, 2024 08:30 ET

Express News | Sonoma Pharmaceuticals Inc - to Resume Selling Acuicyn, Celacyn, Epicyn, Lasercyn, Levicyn in U.S.

ReutersNov 21, 2024 16:41 ET

Sonoma Pharmaceuticals Ends EMC Pharma Agreement

TipRanksNov 21, 2024 16:31 ET

Express News | Sonoma Pharmaceuticals Terminates Agreement With EMC Pharma After It Did Not Meet Minimum Purchase Requirements

BenzingaNov 21, 2024 16:15 ET

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

AccesswireNov 21, 2024 16:06 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 19, 2024 16:05 ET